Clinical Trial Update: Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients

View source ↗

Summary

This clinical trial investigates plasma and urinary cell-free DNA as biomarkers for kidney transplant rejection. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Snippet

Sponsor: Poulet Geoffroy | Conditions: Transplant Rejection, Transplant Kidney | Status: RECRUITING